Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)

NCT01611142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral T-Cell Lymphoma

Interventions

BIOLOGICAL: KW-0761 (mogamulizumab)

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]